Clinical Trial: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987539) titled 'A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)' on May 16.

Brief Summary: The primary objectives of this study are to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of inebilizumab administered in pediatric participants with gMG, and to assess the safety and tolerability of inebilizumab administered in pediatric participants with gMG.

Study Start Date: Aug. 29, 2025

Study Type: INTERVENTIONAL

Condition: Generalized Myasthenia Gravis

Intervention: DRUG: Inebilizumab

Inebilizumab will be administered IV.

R...